Healis Therapeutics asset CKDB-501A shares Phase III topline results for glabellar injections from CKD Bio in South Korea streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Healis Therapeutics Announces Supply Agreement with CKD Bio to develop CKDB-501 for neuropsychiatric indications tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
The latest cohort of 150 Schwarzman Scholars has been chosen, representing 43 countries and 114 universities. They will begin their studies in China in August 2024.